Background illustration for clinical trials search

Paid Clinical Trials Ohio

Discover 3,089 paid clinical trials in Ohio. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

for
Urinary Bladder Neoplasms,
Location: Moncton, Sherbrooke, New York NY, Bala-Cynwyd PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06833073

Phase 2, Recruiting

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

for
Clonal Cytopenia of Undetermined Significance
Location: New York NY, Miami FL, Columbus OH, Nashville TN,
Sponsor: Uma Borate

Sex: All

Age: 18+

Code: NCT05641831

Phase 2, Recruiting

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

for
Prostate Cancer (Adenocarcinoma), Prostate CA, Prostate Cancers,
Location: Myrtle Beach SC, Gahanna OH
Sponsor: Cellvax Therapeutics Inc

Sex: Male

Age: 0+

Code: NCT06636682

Phase 2, Recruiting

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

for
Pancreatic Neoplasm
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05961982

Recruiting

Automated Deep Brain Stimulation Programming Using Functional Mapping

for
Parkinson Disease
Location: Winston-Salem NC, Charlotte NC, Columbus OH
Sponsor: Great Lakes NeuroTechnologies Inc.

Sex: All

Age: 35 - 70+

Code: NCT02765282

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

for
Thrombocythemia, Essential, Primary Myelofibrosis,
Location: Durham NC, Pittsburgh PA, Columbus OH, Ann Arbor MI
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06351631

Phase 3, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Commack NY, Berlin Corners VT, Uniondale NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase 2, Recruiting

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

for
Acute Pancreatitis
Location: Baltimore MD, Pittsburgh PA, Orlando FL, Gainesville FL,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05197920

Recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

for
Advanced Solid Tumors
Location: Cincinnati OH, Houston TX, Salt Lake City UT
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT06096974

Phase 1, Recruiting

Study of Olutasidenib and Temozolomide in HGG

for
High Grade Glioma, Astrocytoma, Astrocytoma, Grade III,
Location: Durham NC, Miami FL, Columbus OH, Cincinnati OH,
Sponsor: Rigel Pharmaceuticals

Sex: All

Age: 12 - 39

Code: NCT06161974

Phase 2, Recruiting

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

for
Relapsed Sarcomas
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05210374

Phase 1, Recruiting

HA35 Acute Alcohol Study

for
Healthy Controls
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 21 - 65

Code: NCT05025865

Early Phase 1, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Boston MA, Garden City NY, New York NY, Lake Success NY,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

for
Metastatic Digestive System Neuroendocrine Tumor G1,
Location: St. John's, Quebec, Ottawa, Rochester NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05773274

Phase 2, Recruiting

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

for
Unresectable Melanoma, Metastatic Melanoma,
Location: New York NY, Miami FL, Pittsburgh PA, Orlando FL,
Sponsor: Iovance Biotherapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT05361174

Phase 1, Phase 2, Recruiting

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

for
Chronic Lymphocytic Leukemia, Richter's Transformation
Location: Boston MA, Chapel Hill NC, Columbus OH, Atlanta GA
Sponsor: Christine Ryan

Sex: All

Age: 18+

Code: NCT06043674

Phase 2, Recruiting

Postoperative Pain After Activation of Irrigant

for
Pain
Location: Cleveland OH
Sponsor: Cleveland Dental Institute

Sex: All

Age: 18 - 50

Code: NCT06528574

Recruiting

Prevention of ProliFerative Vitreoretinopathy With Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial

for
Proliferative Vitreoretinopathy,
Location: Cincinnati OH
Sponsor: Cincinnati Eye Institute, Southwest Ohio

Sex: All

Age: 18+

Code: NCT06541574

Phase 2, Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

for
Duchenne Muscular Dystrophy
Location: Gainesville FL, St. Petersburg FL, Cincinnati OH,
Sponsor: Catalyst Pharmaceuticals, Inc.

Sex: Male

Age: 2+

Code: NCT06564974

Recruiting

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

for
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Location: Baltimore MD, Washington D.C. DC, Cleveland OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 0

Code: NCT04786574

Phase 3, Recruiting

Popular cities in Ohio

With a robust healthcare network, renowned medical research centers, and innovative treatments, Ohio is a leading destination for a wide range of clinical trials. Institutions such as the Cleveland Clinic, Ohio State University Wexner Medical Center, University Hospitals Cleveland Medical Center, and Nationwide Children’s Hospital are at the forefront of these studies.

Why choose Ohio for clinical trials?

Ohio offers distinct advantages in the clinical research landscape. The state's diverse population provides a wide range of participants, enhancing the accuracy and relevance of research outcomes. Ohio is also recognized for its strong research environment, with a focus on medical innovation and pioneering studies in various fields.

By choosing to participate in a clinical trial in Ohio, participants contribute to vital medical research while benefiting from a well-established clinical trial infrastructure supported by top-tier healthcare institutions. This ensures they receive cutting-edge care and support throughout the process.

Common conditions studied in Ohio

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Ohio